|
1
|
Akool el-S, Doller A, Babelova A,
Tsalastra W, Moreth K, Schaefer L, Pfeilschifter J and Eberhardt W:
Molecular mechanisms of TGF beta receptor-triggered signaling
cascades rapidly induced by the calcineurin inhibitors cyclosporin
A and FK506. J Immunol. 181:2831–2845. 2008. View Article : Google Scholar
|
|
2
|
Trachtman H, Vento s, Gipson D, et al:
Novel therapies for resistant focal segmental glomerulosclerosis
(FONT) phase II clinical trial: study design. BMC Nephrol.
12:82011. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Ponticelli C and Passerini P: Other
immunosuppressive agents for focal segmental glomerulosclerosis.
Semin Nephrol. 23:242–248. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Sabuda-Widemann D, Grabensee B, Schwandt C
and Blume C: Mycophenolic acid inhibits the autocrine PDGF-B
synthesis and PDGF-BB-induced mRNA expression of Egr-1 in rat
mesangial cells. Nephrol Dial Transplant. 24:52–61. 2009.
View Article : Google Scholar
|
|
5
|
Radeke HH, Kuster S, Kaever V and Resch K:
Effects of cyclosporin and FK-506 on glomerular mesangial cells.
Evidence for direct inhibition of thromboxane synthase by low
cyclosporin concentrations. Eur J Clin Pharmacol. 44(Suppl 1):
S11–S16. 1993. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Miao L, Sun J, Yuan H, Jia Y and Xu Z:
Combined therapy of low-dose tacrolimus and prednisone in nephrotic
syndrome with slight mesangial proliferation. Nephrology (Carlton).
11:449–454. 2006. View Article : Google Scholar
|
|
7
|
Pastukhov O, Schwalm S, Römer I,
Zangemeister-Wittke U, Pfeilschifter J and Huwiler A: Ceramide
kinase contributes to proliferation but not to prostaglandin E2
formation in renal mesangial cells and fibroblasts. Cell Physiol
Biochem. 34:119–133. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Anil KMS, Irfan SM, Ranganna K, Malat G,
Sustento-Reodica N, Kumar AM and Meyers WC: Comparison of four
different immunosuppression protocols without long-term steroid
therapy in kidney recipients monitored by surveillance biopsy:
five-year outcomes. Transpl Immunol. 20:32–42. 2008. View Article : Google Scholar
|
|
9
|
Boletis J, Balitsari A, Filiopoulos V,
Stamataki E, Lionaki S, Zavos G and Kostakis A: Delayed renal graft
function: the influence of immunosuppression. Transplant Proc.
37:2054–2059. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Ren H, Guo N and Lu D: Successful
engraftment of HLA-identical sibling cord blood transplantation in
an adult with chronic myelogenous leukemia. Chinese Journal of
Hematology. 22:621–624. 2001.(In Chinese).
|
|
11
|
Kurogi Y: Mesangial cell proliferation
inhibitors for the treatment of proliferative glomerular disease.
Med Res Rev. 23:15–31. 2003. View Article : Google Scholar
|
|
12
|
Delarue F, Virone A, Hagege J, Lacave R,
Peraldi MN, Adida C, Rondeau E, Feunteun J and Sraer JD: Stable
cell line of T-SV40 immortalized human glomerular visceral
epithelial cells. Kidney Int. 40:906–912. 1991. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Ruan XZ, Varghese Z, Fernando R and
Moorhead JF: Cytokine regulation of low-density lipoprotein
receptor gene transcription in human mesangial cells. Nephrol Dial
Transplant. 13:1391–1397. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Pereira RL, Felizardo RJ, Cenedeze MA, et
al: Balance between the two kinin receptors in the progression of
experimental focal and segmental glomerulosclerosis in mice. Dis
Mod Mech. 7:701–710. 2014. View Article : Google Scholar
|
|
15
|
Liu CY, Zhou LL, Cheng Q, Jiang SN, Sheng
J, Sun JD and Zhao JY: Effect of bradykinin on renal mesangial cell
proliferation and extracellular matrix secretion. Genet Mol Res.
13:490–498. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Jennings P, Koppelstaetter C, Aydin S,
Abberger T, Wolf AM, Mayer G and Pfaller W: Cyclosporine A induces
senescence in renal tubular epithelial cells. Am J Physiol Renal
Physiol. 293:F831–F838. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Choi SJ, You HS and Chung SY:
Tacrolimus-induced apoptotic signal transduction pathway.
Transplant Proc. 40:2734–2736. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Migita K and Eguchi K: FK 506-mediated
T-cell apoptosis induction. Transplant Proc. 33:2292–2293. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Park JW, Bae EH, Kim IJ, Ma SK, Choi C,
Lee J and Kim SW: Paricalcitol attenuates cyclosporine-induced
kidney injury in rats. Kidney Int. 77:1076–1085. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
de Arriba G, de Hornedo JP, Rubio SR,
Fernández MC, Martinez SB, Camarero MM and Cid TP: Vitamin E
protects against the mitochondrial damage caused by cyclosporin A
in LLC-PK1 cells. Toxicol Appl Pharmacol. 239:241–250. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Bladh LG, Lidén J, Pazirandeh A, Rafter I,
Dahlman-Wright K, Nilsson S and Okret S: Identification of target
genes involved in the antiproliferative effect of glucocorticoids
reveals a role for nuclear factor-(kappa)B repression. Mol
Endocrinol. 19:632–643. 2005. View Article : Google Scholar
|
|
22
|
Rogatsky I, Trowbridge JM and Garabedian
MJ: Glucocorticoid receptor-mediated cell cycle arrest is achieved
through distinct cell-specific transcriptional regulatory
mechanisms. Mol Cell Biol. 17:3181–3193. 1997.PubMed/NCBI
|
|
23
|
Smith E, Redman RA, Logg CR, Coetzee GA,
Kasahara N and Frenkel B: Glucocorticoids inhibit developmental
stage-specific osteoblast cell cycle. Dissociation of cyclin
A-cyclin-dependent kinase 2 from E2F4-p130 complexes. J Biol Chem.
275:19992–20001. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Rhee K, Reisman D, Bresnahan W and
Thompson EA: Glucocorticoid regulation of G1 cyclin-dependent
kinase genes in lymphoid cells. Cell Growth Differ. 6:691–698.
1995.PubMed/NCBI
|
|
25
|
Helmberg A, Auphan N, Caelles C and Karin
M: Glucocorticoid-induced apoptosis of human leukemic cells is
caused by the repressive function of the glucocorticoid receptor.
EMBO J. 14:452–460. 1995.PubMed/NCBI
|
|
26
|
Sánchez I, Goya L, Vallerga AK and
Firestone GL: Glucocorticoids reversibly arrest rat hepatoma cell
growth by inducing an early G1 block in cell cycle progression.
Cell Growth Differ. 4:215–225. 1993.PubMed/NCBI
|
|
27
|
Corroyer S, Nabeyrat E and Clement A:
Involvement of the cell cycle inhibitor CIP1/WAF1 in lung alveolar
epithelial cell growth arrest induced by glucocorticoids.
Endocrinology. 138:3677–3685. 1997.PubMed/NCBI
|
|
28
|
Cha HH, Cram EJ, Wang EC, Huang AJ, Kasler
HG and Firestone GL: Glucocorticoids stimulate p21 gene expression
by targeting multiple transcriptional elements within a steroid
responsive region of the p21waf1/cip1 promoter in rat hepatoma
cells. J Biol Chem. 273:1998–2007. 1998. View Article : Google Scholar : PubMed/NCBI
|
